Published in

Cell Press, American Journal of Human Genetics, 4(85), p. 536, 2009

DOI: 10.1016/j.ajhg.2009.09.010

Cell Press, American Journal of Human Genetics, 2(85), p. 155-167, 2009

DOI: 10.1016/j.ajhg.2009.06.015

Links

Tools

Export citation

Search in Google Scholar

Identification of an Agrin Mutation that Causes Congenital Myasthenia and Affects Synapse Function

Journal article published in 2009 by Caroline Huzé, Stéphanie Bauché ORCID, Frédéric Chevessier, Evelyne Goillot, Pascale Richard ORCID, Karen Gaudon, Asma Ben Ammar, Annie Chaboud, Andrée Rouche, Isabelle Grosjean, Heba-Aude Lecuyer, Véronique Bernard, Nektaria Alexandri, Markus A. Rüegg, Thierry Kuntzer and other authors.
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

We report the case of a congenital myasthenic syndrome due to a mutation in AGRN, the gene encoding agrin, an extracellular matrix molecule released by the nerve and critical for formation of the neuromuscular junction. Gene analysis identified a homozygous missense mutation, c.5125G>C, leading to the p.Gly1709Arg variant. The muscle-biopsy specimen showed a major disorganization of the neuromuscular junction, including changes in the nerve-terminal cytoskeleton and fragmentation of the synaptic gutters. Experiments performed in nonmuscle cells or in cultured C2C12 myotubes and using recombinant mini-agrin for the mutated and the wild-type forms showed that the mutated form did not impair the activation of MuSK or change the total number of induced acetylcholine receptor aggregates. A solid-phase assay using the dystrophin glycoprotein complex showed that the mutation did not affect the binding of agrin to alpha-dystroglycan. Injection of wild-type or mutated agrin into rat soleus muscle induced the formation of nonsynaptic acetylcholine receptor clusters, but the mutant protein specifically destabilized the endogenous neuromuscular junctions. Importantly, the changes observed in rat muscle injected with mutant agrin recapitulated the pre- and post-synaptic modifications observed in the patient. These results indicate that the mutation does not interfere with the ability of agrin to induce postsynaptic structures but that it dramatically perturbs the maintenance of the neuromuscular junction.